Join our community of smart investors

Major restructuring at Tate

Tate and Lyle has announced a massive restructuring programme, following a profit warning last year.
April 22, 2015

Ingredients giant Tate & Lyle (TATE) has announced major plans to realign the business to focus on the faster-growing and higher-margin speciality food ingredients market.

IC TIP: Hold at 619p

As part of the new approach, Tate will sell the majority of its European Bulk Ingredients business, which it operates under a joint venture with US-listed Archer Daniels Midland (US:ADM), while strengthening the speciality food ingredients operation by acquiring full ownership of the more speciality-focused plant in Slovakia. The disposal should bring in €240m (£171m) in cash on completion, which could yield a net profit of £60m after exceptional charges.

The group will also restructure the struggling Splenda Sucralose business by closing the Singapore plant and consolidating production into the US facility.